By David Prince, MD | Montefiore Medical Center Although new GLP-1 agonist weight loss drugs such as Ozempic, Wegovy, Trulicity, and Byetta are currently dominating the headlines, the majority of overweight Americans may not qualify for these medications due to limited availability and insurance plan restrictions
Typically, patients of our weight loss program in East Worcester, New York who start FDA-approved GLP-1 medications like Ozempic and Wegovy lose an average 15% of their weight when combined with diet and exercise
Aboud OA, Habib SL, Trott J, Stewart B, Liang S, Chaudhari AJ, et al
Semaglutide has immunomodulatory and antitumor effects in a mouse model of breast cancer
Xu, Y., et al., 2021
Attia also underscores the importance of muscle mass and strength, particularly as we age